Structural insights into the broad-spectrum antiviral target endoplasmic reticulum alpha-glucosidase II
Targeting the host-cell endoplasmic reticulum quality control (ERQC) pathway is an effective broad-spectrum antiviral strategy. The two ER resident α-glucosidases whose sequential action permits entry in this pathway are the targets of glucomimetic inhibitors. Knowledge of the molecular details of t...
Main Authors: | Zitzmann, N, Caputo, AT, Alonzi, DS, Kiappes, JL, Struwe, WB, Cross, A, Basu, S, Darlot, B, Roversi, P |
---|---|
Other Authors: | Hilgenfeld, R |
Format: | Book section |
Language: | English |
Published: |
Springer
2018
|
Similar Items
-
Structural studies of Endoplasmic Reticulum Glucosidase II
by: Caputo, A, et al.
Published: (2015) -
Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals
by: Caputo, A, et al.
Published: (2016) -
ToP-DNJ, a selective inhibitor of endoplasmic reticulum α-glucosidase II exhibiting anti-flaviviral activity
by: Kiappes, JL, et al.
Published: (2017) -
Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
by: Warfield, KL, et al.
Published: (2016) -
N-substituted valiolamine derivatives as potent inhibitors of endoplasmic reticulum α-glucosidases I and II with antiviral activity
by: Karade, S, et al.
Published: (2021)